Aurinia Pharmaceuticals
AUPH
$5.10
Share price
-1.35%
Change (1 day)
-56.37%
Change (1 year)
Categories
P/S ratio for Aurinia Pharmaceuticals (AUPH)
P/S ratio as of May 2024 (TTM): 4.21
According to Aurinia Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.21284. At the end of 2023 the company had a P/S ratio of 7.36.
P/S ratio history for Aurinia Pharmaceuticals from 2009 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 7.36 | 60.59% |
| 2022 | 4.58 | -92.96% |
| 2021 | 65.0 | 86.98% |
| 2020 | 34.8 | -99.51% |
| 2019 | > 1000 | 462.36% |
| 2018 | > 1000 | 37.8% |
| 2017 | 913 | 89.43% |
| 2016 | 482 | 39.9% |
| 2015 | 345 | -15.79% |
| 2014 | 409 | 752.87% |
| 2013 | 48.0 | 2633.42% |
| 2012 | 1.76 | -91.88% |
| 2011 | 21.6 | 81.59% |
| 2010 | 11.9 | 58.19% |
| 2009 | 7.53 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | 7.88 | 86.95% | 🇺🇸 USA |
 Pieris Pharmaceuticals PIRS | 0.2935 | -93.03% | 🇺🇸 USA |
 Aeterna Zentaris AEZS | 2.17 | -48.49% | 🇺🇸 USA |